Conferences
ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
European Lung Cancer Congress 2020
15 - 18 Apr 2020
-, Geneva, Switzerland
The ELCC 2020 Congress - due to take place 15-18 April in Geneva, Switzerland - was cancelled due to the Coronavirus outbreak.
Background of the KEYNOTE-158 trial for pembrolizumab in advanced mesothelioma
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
Preclinical models for small-cell lung cancer
Prof Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands
Do immune checkpoint inhibitors work in EGFR mutant lung cancer?
Dr Edward Garon - UCLA Medical Center, Santa Monica, USA
Managing toxicities associated with immune-checkpoint inhibitors
Prof Olivier Lambotte - Hôpitaux de Paris, Paris, France
New oncogenic drivers in NSCLC
Prof Egbert Smit - Netherlands Cancer Institute, Amsterdam, Netherlands
The potential of KRAS inhibitors for non-small-cell lung cancer
Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany